APPLICATION
ANDA200904
TYPE
ANDA
ORIGINAL APPROVAL
2015-07-16
LATEST ACTION
2025-07-03
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
LINEZOLIDPrescription
LINEZOLID 200MG/100ML (2MG/ML) · SOLUTION · INTRAVENOUS
LINEZOLIDPrescription
LINEZOLID 600MG/300ML (2MG/ML) · SOLUTION · INTRAVENOUS
Approval history
2025-07-03Labeling · Supplement 16 · standardAP
2023-12-22Labeling · Supplement 14 · standardAP
2023-12-22Labeling · Supplement 12 · standardAP
2023-12-22Labeling · Supplement 13 · standardAP
2023-12-22Labeling · Supplement 11 · standardAP
2019-05-28Labeling · Supplement 8 · standardAP
2019-05-28Labeling · Supplement 4 · standardAP
2015-07-16Not Applicable · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.